Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study

OBJECTIVE: The treatment outcome of direct-acting antivirals (DAAs) in chronic hepatitis C patients with hepatocellular carcinoma (HCC) is controversial. The current study aimed to address the treatment efficacy and safety of DAAs in patients with curative or active HCC, compared with those of patie...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:BMJ Open
मुख्य लेखकों: Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Wei, Yu-Ju, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMJ Publishing Group 2019
विषय:
Gastroenterology and Hepatology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501994/
https://ncbi.nlm.nih.gov/pubmed/31061041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-026703
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन